Myocardial infarction and COVID‑19 in a “non‑COVID” hospital: epidemiology, annual analysis

Abstract

Purpose of the work: to assess the prevalence of myocardial infarction and COVID-19 in a «non-COVID» hospital.Materials and methods: the first part of the work is monitoring data from June 2020 to May 2021, the second part is an analysis of monitoring from August 2017 to May 2021.Research results. According to the data obtained, the peak of the combination of myocardial infarction with COVID-19 lagged behind the total pool of COVID-19 patients by a month, while there was a decrease in the overall incidence of unstable angina pectoris and an increase in the number of patients with myocardial infarction. Obviously, people were slow to seek medical attention. This led to an increase in the time from the onset of symptoms to hospital admission, a later initiation of treatment, and an increase in the incidence of thrombosis in COVID-19 survivors.Conclusions. In patients, myocardial infarction predominated in the structure of acute coronary syndrome in patients, which is associated, on the one hand, with an increase in the time from the onset of symptoms to admission to the hospital and an increased risk of thrombosis in persons who have undergone COVID-19.